Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Opendoor Technologies Inc (OPEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Opendoor Technologies Inc — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B), while Opendoor Technologies Inc trades at $1.96 (market cap $1.93B). The key difference: Kymera Therapeutics Inc. Common Stock is far larger — about 4.6× Opendoor Technologies Inc's market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, Opendoor Technologies Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Opendoor Technologies Inc for 33 Days on average.
| KYMR | OPEN | |
|---|---|---|
Market Cap | $8.88B | $1.93B |
Volume | 1,028,790 | 49,178,020 |
Sector | Health | Real Estate |
52-Week High | $127.31 | $9.37 |
52-Week Low | $55.80 | $1.99 |
Typical Hold Time | 0 Days | 33 Days |
Enterprise Value | $8.27B | $3.00B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Opendoor Technologies (OPEN) trades at $2.11, down 86% from its peak, with bearish technical signals and mixed quarterly earnings. The company shows declining revenue from $15.6B in 2022 to $4.4B in 2025, with persistent net losses widening to -$1.3B. Recent news highlights mortgage expansion to 35-40 states by end-2026 and a $100,000 insider purchase by the CEO, while housing market volatility and rate hike concerns pressure the stock.
The outlook remains challenged by high debt, negative margins, and housing sector headwinds, but analyst consensus targets $4.92 imply 133% upside. Key risks include execution on profitability, interest rate sensitivity, and competitive pressures. The stock's deep valuation discount (P/S 0.54) offers potential if operational turnaround succeeds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Opendoor Technologies Inc
Opendoor Technologies Inc is a digital platform for residential real estate. This platform enables customers to buy and sell houses online. It generates revenue through home sales, along with other revenue from real estate services.
Read more on OPEN →
